4//SEC Filing
REPLIGEN CORP 4
Accession 0001140361-16-065155
$RGENCIK 0000730272operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 3:38 PM ET
Size
7.2 KB
Accession
0001140361-16-065155
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
COOPER GLENN L MD
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-05-11+3,366→ 3,366 totalExercise: $26.12From: 2017-05-11Exp: 2026-05-11→ Common Stock (3,366 underlying) - Award
Common Stock
2016-05-11+1,763→ 37,094 total
Footnotes (2)
- [F1]Dr. Cooper was awarded 1,763 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest on May 11, 2017. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Award vests in full one year from grant date on May 11, 2017.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 3:38 PM ET
- Size
- 7.2 KB